NUP107 Antibody

What is NUP107 and why is it important in cellular biology?

NUP107 (nucleoporin 107) is a critical component of the nuclear pore complex (NPC), a protein assembly localized at the nuclear rim that mediates macromolecular transport between the nucleus and cytoplasm. The protein is approximately 106.4 kilodaltons in mass and functions as a "keystone nucleoporin" required for the assembly of a subset of nucleoporins into the NPC structure . NUP107 is part of a heterooligomeric complex containing several other nucleoporins including NUP160, NUP133, NUP96, and the mammalian homolog of yeast sec13p . This complex plays crucial roles beyond nuclear transport, including functions in mitotic spindle assembly, making NUP107 a multifunctional protein essential for cellular integrity and function .

What are the alternative names and known homologs of NUP107?

NUP107 is known by several alternative names in scientific literature and databases:

• Nuclear pore complex protein Nup107

• 107 kDa nucleoporin

• Nucleoporin 107kDa

• p105

• NPHS11

• NUP84

• ODG6

• GAMOS7

NUP107 has homologs across various species. In yeast, Nup84p is the homolog of mammalian Nup107 . Based on gene similarity, orthologous proteins may exist in fly, canine, porcine, monkey, mouse, and rat species . This conservation across species highlights the evolutionary importance of this protein in eukaryotic cells.

What experimental applications are NUP107 antibodies suitable for?

NUP107 antibodies are suitable for multiple experimental applications in research settings:

The choice of application should be determined by specific research questions and experimental design. For optimal results, researchers should follow manufacturer-recommended protocols for antibody dilution and sample preparation .

How should I validate a NUP107 antibody before using it in my experiments?

Proper validation of NUP107 antibodies is critical for ensuring experimental rigor and reproducibility. A comprehensive validation approach should include:

• Specificity Testing: Verify antibody specificity using multiple methods:

  • Western blot analysis using positive controls such as A549 cell lysates

  • RNA interference (RNAi) experiments to confirm signal reduction after NUP107 knockdown

  • Comparison of staining patterns with previously validated antibodies

• Cross-Reactivity Assessment: If working across species, confirm reactivity with your target species. Many NUP107 antibodies react with human, mouse, and rat samples, but specificity may vary between products .

• Application-Specific Validation:

  • For immunofluorescence: Confirm nuclear rim staining pattern characteristic of nucleoporins

  • For Western blot: Verify detection of a band at approximately 107 kDa

  • For quantitative applications: Establish standard curves and determine linear detection range

• Positive and Negative Controls: Include appropriate controls in all experiments:

  • Positive control: Samples known to express NUP107 (e.g., A549 cells)

  • Negative control: Samples with NUP107 depletion or antibody pre-absorbed with blocking peptide such as PEP-0682

These validation steps will help ensure that experimental results accurately reflect NUP107 biology and are not artifacts of cross-reactivity or non-specific binding.

What are the optimal immunostaining protocols for detecting NUP107 in different cell types?

Optimal immunostaining protocols for NUP107 detection vary depending on cell type and fixation methods. Based on established research practices:

• Fixation Options:

  • Paraformaldehyde (4%) fixation for 10-15 minutes preserves NPC structure while maintaining epitope accessibility

  • Methanol fixation (-20°C for 5 minutes) may be preferred for certain epitopes, especially when examining nuclear envelope structures

• Permeabilization:

  • 0.2-0.5% Triton X-100 for 5-10 minutes is typically sufficient

  • For nuclear envelope proteins, gentler permeabilization using 0.1% saponin may better preserve structural details

• Blocking and Antibody Dilutions:

  • Block with 5% normal serum (matching secondary antibody host) or BSA

  • Primary antibody dilutions ranging from 1:50-1:500 are recommended for immunocytochemistry

  • Incubation at 4°C overnight often yields optimal signal-to-noise ratio

• Cell Type-Specific Considerations:

  • HeLa cells show characteristic nuclear rim staining with anti-NUP107 antibodies

  • A549 cells are recommended as positive controls for many commercial antibodies

  • For primary cells or tissues, antigen retrieval steps may be necessary to expose epitopes

• Co-staining Recommendations:

  • Co-staining with other NPC components (such as NUP133 or NUP96) can provide valuable context

  • For mitotic studies, co-staining with kinetochore markers helps identify the non-NPC pool of NUP107

Regardless of the specific protocol, inclusion of appropriate controls is essential for accurate interpretation of results.

How can I troubleshoot weak or non-specific signals when using NUP107 antibodies?

When encountering weak signals or non-specific background with NUP107 antibodies, systematic troubleshooting can help identify and resolve these issues:

• For Weak Signals:

  • Increase antibody concentration incrementally (starting from manufacturer recommendations)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Optimize antigen retrieval methods, especially for fixed tissues

  • Use signal amplification systems (e.g., biotin-streptavidin systems)

  • Verify sample preparation and protein expression levels

  • Check if the epitope is masked by protein interactions or post-translational modifications

• For High Background or Non-specific Signals:

  • Increase blocking stringency (5-10% serum or BSA)

  • Add 0.1-0.3% Triton X-100 to antibody diluent

  • Include additional washing steps with higher salt concentration

  • Pre-absorb antibody with blocking peptide when available

  • Reduce primary and secondary antibody concentrations

  • Filter secondary antibodies before use to remove aggregates

• Application-Specific Troubleshooting:

  • For Western blot: Optimize transfer conditions for high molecular weight proteins

  • For IF/ICC: Test different fixation methods that may better preserve epitope structure

  • For flow cytometry: Ensure adequate permeabilization for intracellular targets

• Sample-Specific Considerations:

  • Cell cycle state may affect NUP107 localization and abundance

  • Species differences may require antibody optimization

  • Certain cell types may express variant isoforms

Creating a systematic optimization matrix that varies one parameter at a time can help identify optimal conditions for your specific experimental system.

How does NUP107 depletion affect nuclear pore complex assembly and cellular function?

NUP107 depletion has profound effects on nuclear pore complex assembly and varied impacts on cellular functions:

• Effects on NPC Structure and Assembly:

  • NUP107 functions as a "keystone nucleoporin" essential for proper assembly of the NPC

  • Depletion prevents the assembly of several peripheral nucleoporins including Nup358 and Nup214 on the cytoplasmic side, and Nup153 on the nucleoplasmic side

  • The filamentous NPC-associated protein Tpr also fails to assemble in Nup107-depleted cells

  • Interestingly, p62, a nucleoporin at the center of the NPC, remains unaffected by NUP107 depletion

• Functional Consequences:

  • Despite significant structural changes to the NPC, NUP107 depletion causes only a partial inhibition of mRNA export

  • Surprisingly, cell growth rates remain largely unaffected, suggesting functional redundancy within the mammalian NPC system

  • NUP107-depleted cells show defects in spindle assembly during mitosis

• Molecular Mechanism:

  • When NUP107 is depleted, components of its complex (including Nup133) fail to localize properly to the nuclear envelope

  • Proteins that interact with the NUP107 complex are often degraded when they cannot assemble properly into the NPC

  • RT-PCR analysis confirms that this depletion occurs post-transcriptionally, as mRNA levels for co-depleted proteins remain unchanged

These findings highlight NUP107's role as an architectural organizer of the NPC rather than directly influencing all transport functions, explaining the partial functionality of NPCs despite structural deficiencies.

What is the relationship between NUP107 and disease states such as nephrotic syndrome?

NUP107 has emerging roles in disease pathophysiology, particularly in kidney disorders:

• Nephrotic Syndrome and Glomerular Function:

  • NUP107 dysfunction impacts the glomerular filtration barrier in nephrotic syndrome

  • It demonstrates interrelated pathological effects with other key proteins like nephrin and podocin in podocyte function

  • NUP107 is associated with the disease designation NPHS11, indicating its clinical relevance in nephropathy

• Genetic Associations:

  • Mutations in NUP107 have been identified in cases of genetic nephrotic syndrome

  • The gene is also associated with GAMOS7 (genetic steroid-resistant nephrotic syndrome)

  • These genetic links suggest NUP107's critical role in kidney development and function

• Molecular Mechanisms in Disease:

  • NUP107 is involved in nephrogenesis (kidney development)

  • Disruption of nuclear transport mechanisms in podocytes may contribute to disease progression

  • The NUP107-160 complex may affect gene expression patterns relevant to kidney function

• Other Disease Associations:

  • NUP107 has been identified as an HIV dependency factor (HDF), suggesting potential roles in viral pathogenesis

  • This identification positions NUP107 as a possible drug target for HIV treatment strategies

Understanding the relationship between NUP107 and disease states provides valuable insights for both basic research and potential therapeutic development for kidney disorders and other conditions.

How does NUP107 contribute to mitotic processes beyond its role in nuclear transport?

While primarily known as a component of the nuclear pore complex, NUP107 plays critical roles during mitosis that extend beyond nuclear transport:

• Differential Localization During Mitosis:

  • During mitosis, a subset of the NUP107-160 complex relocates to kinetochores and pro-metaphase spindle poles

  • This relocalization occurs in association with mitotic checkpoint proteins including Mad1, Mad2, Bub3, and Cdc20

  • GFP-tagged NUP107 and NUP133 remain associated during mitosis and target to the reforming nuclear envelope at early stages

• Functional Significance in Spindle Assembly:

  • Immunodepletion studies demonstrate that the NUP107-160 complex is essential for proper spindle assembly

  • Defects in this process can lead to chromosomal segregation errors and genomic instability

  • The complex may serve as a spatial regulator of spindle assembly factors

• Cell Cycle Regulation:

  • FRAP (Fluorescence Recovery After Photobleaching) experiments reveal that NUP107 is tightly attached to NPCs during interphase

  • NUP107 exchange occurs only once per cell cycle, indicating precise temporal regulation

  • This strictly controlled incorporation suggests roles in coordinating nuclear envelope breakdown and reformation

• Molecular Interactions During Mitosis:

  • NUP107 contains numerous kinase consensus sites, suggesting potential regulation by mitotic kinases

  • Its leucine zipper motif may facilitate protein-protein interactions specific to mitotic functions

  • Association with mitotic checkpoint proteins implicates NUP107 in spindle assembly checkpoint signaling

These multifunctional properties position NUP107 at the intersection of nuclear transport, mitotic progression, and genome integrity maintenance, making it a fascinating subject for cell cycle research.

What are the best methods for studying NUP107 protein interactions and complex formation?

Several complementary approaches can be employed to study NUP107 protein interactions and complex formation:

• Co-Immunoprecipitation (Co-IP):

  • Effective for capturing native protein complexes

  • Can be performed with either endogenous proteins using anti-NUP107 antibodies or with tagged recombinant proteins

  • Immunoprecipitation followed by Western blotting can confirm interactions with known partners such as NUP133, NUP96, NUP160, and Sec13

  • Silver staining or mass spectrometry of precipitated complexes can identify novel interaction partners

• Proximity-Based Labeling Techniques:

  • BioID or TurboID approaches using NUP107 fusion proteins can identify proteins in close proximity within the cellular environment

  • APEX2-based proximity labeling provides temporal resolution for dynamic interactions

  • These methods are particularly valuable for studying transient or context-dependent interactions during cell cycle progression

• Fluorescence-Based Approaches:

  • Fluorescence Resonance Energy Transfer (FRET) between fluorescently tagged NUP107 and potential partners

  • Fluorescence Recovery After Photobleaching (FRAP) to study dynamics of NUP107 complex formation, which has revealed that NUP107 exchanges only once per cell cycle

  • Fluorescence Correlation Spectroscopy (FCS) for studying complex formation in solution

• Biochemical Complex Isolation:

  • Size exclusion chromatography to separate native complexes based on molecular weight

  • Sucrose gradient ultracentrifugation for density-based separation

  • Blue native PAGE for preserving native protein complexes

  • The hetero-oligomeric NUP107 complex has been successfully obtained by controlled dissociation of isolated NPCs

• Yeast Two-Hybrid and Mammalian Two-Hybrid:

  • Useful for mapping specific interaction domains

  • Can identify direct protein-protein interactions

  • Split-reporter systems can verify interactions in mammalian cellular contexts

When designing interaction studies, it's important to consider that NUP107 exists in different subcellular pools (NPC-associated and kinetochore/spindle pole-associated during mitosis) that may have distinct interaction partners .

How can I effectively knockdown or knockout NUP107 for functional studies?

Effective depletion of NUP107 can be achieved through several approaches, each with specific advantages for different experimental questions:

• RNA Interference (RNAi):

  • siRNA transfection has been successfully used to deplete NUP107 in HeLa cells with 70-90% transfection efficiency

  • Effective knockdown can be achieved within 48 hours post-transfection

  • Validation of knockdown should include both Western blot analysis and immunofluorescence microscopy

  • This approach allows for temporal control and is suitable for studying acute effects of NUP107 depletion

• CRISPR-Cas9 Genome Editing:

  • For complete knockout studies or generation of stable cell lines

  • Design multiple guide RNAs targeting early exons of NUP107

  • Consider using inducible CRISPR systems if complete knockout is lethal

  • Screen clones by sequencing and protein expression analysis

• Inducible Knockdown Systems:

  • Tetracycline-inducible shRNA expression allows for controlled timing of depletion

  • Particularly useful for studying dose-dependent effects or temporal requirements

  • Enables reversal of knockdown by tetracycline withdrawal

• Degradation-Based Approaches:

  • Auxin-inducible degron (AID) tagging allows rapid protein depletion

  • PROTAC-based targeted protein degradation

  • These methods offer advantages in studying immediate consequences of protein loss

• Experimental Considerations:

  • Include appropriate controls (non-targeting siRNA/sgRNA)

  • Assess potential off-target effects through rescue experiments

  • Monitor cell viability, as published data indicates that despite NUP107 depletion, there is often no significant effect on cell growth rate

  • Consider examining effects on interacting partners, as some (like Nup358, Nup214, Nup153, and Tpr) are co-depleted after NUP107 knockdown

The choice of depletion strategy should be guided by experimental goals, timeframe, and the specific aspects of NUP107 function under investigation.

What are the current challenges in studying NUP107 isoforms and their specific functions?

Studying NUP107 isoforms presents several technical and conceptual challenges:

• Isoform Identification and Characterization:

  • Multiple isoforms of NUP107 are known to exist, but comprehensive characterization is lacking

  • RNA sequencing and alternative splicing analysis are needed to identify all possible transcript variants

  • Mass spectrometry approaches with sufficient coverage are required to confirm protein-level expression of predicted isoforms

  • Current antibodies may not distinguish between different isoforms, limiting isoform-specific detection

• Isoform-Specific Reagents and Approaches:

  • Development of isoform-specific antibodies requires identification of unique epitopes

  • Design of isoform-specific primers for RT-PCR quantification

  • CRISPR-based strategies for isoform-specific tagging or knockout

  • RNA interference targeting isoform-specific exons may have limited specificity

• Functional Differentiation:

  • Determining whether different isoforms have distinct subcellular localizations

  • Identifying isoform-specific protein interaction partners

  • Assessing potential tissue-specific or developmental expression patterns

  • Evaluating differential responses to cellular stresses or stimuli

• Physiological Relevance:

  • Connecting isoform expression to disease states or physiological conditions

  • Understanding potential roles in tissue-specific functions like nephrogenesis

  • Determining regulatory mechanisms controlling isoform expression

  • Assessing evolutionary conservation of isoforms across species

• Technical Approaches to Address These Challenges:

  • Isoform-specific tagging using CRISPR-Cas9 knock-in strategies

  • Single-cell RNA sequencing to detect cell-type-specific isoform expression

  • Advanced imaging techniques like super-resolution microscopy to detect potential differential localization

  • Proteomic approaches focusing on tissue-specific or context-dependent expression

Progress in addressing these challenges will require integration of genomic, transcriptomic, and proteomic approaches, combined with functional validation through targeted perturbation of specific isoforms.

How is NUP107 involved in viral infection processes and potential therapeutic targeting?

NUP107's involvement in viral infection processes represents an emerging area of research with therapeutic implications:

This research direction represents a promising intersection between basic nuclear transport biology and translational virology with potential therapeutic applications.

What recent advances have been made in understanding NUP107's role in cell differentiation and development?

Recent research has expanded our understanding of NUP107's functions beyond nuclear transport to include significant roles in cellular differentiation and development:

• Nephrogenesis and Kidney Development:

  • NUP107 has been implicated in nephrogenesis, the process of kidney development

  • Its dysfunction impacts the glomerular filtration barrier, with associated proteins like nephrin and podocin demonstrating interrelated pathological effects

  • The identification of NUP107 mutations in genetic forms of nephrotic syndrome highlights its developmental importance

• Cell Differentiation Processes:

  • Emerging evidence suggests that nucleoporins including NUP107 may regulate gene expression programs during differentiation

  • The composition of nuclear pore complexes changes during differentiation, potentially influencing selective transport of developmental regulators

  • The NUP107-160 complex may interact with chromatin during development to establish cell type-specific gene expression patterns

• Stem Cell Biology:

  • Research into pluripotent stem cells suggests nucleoporins play roles in maintaining stemness and directing differentiation

  • Changes in NUP107 expression or localization may correlate with differentiation state

  • Understanding these relationships could inform improved protocols for directed differentiation in regenerative medicine

• Developmental Timing and Patterning:

  • The strict regulation of NUP107 throughout the cell cycle suggests potential roles in developmental timing mechanisms

  • Its involvement in mitotic processes may influence asymmetric cell divisions important for development

  • Tissue-specific expression patterns may reflect specialized functions in different developmental contexts

• Methodological Advances:

  • Conditional knockout models in specific tissues or developmental stages

  • Live imaging of NUP107 dynamics during developmental processes

  • Single-cell approaches to map expression changes during differentiation trajectories

  • Tissue-specific proteomics to identify context-dependent interaction partners

These emerging research areas highlight NUP107's multifunctional nature beyond its structural role in nuclear pores, positioning it as an important factor in understanding the intersection between nuclear organization, gene regulation, and developmental processes.

How can cutting-edge imaging techniques enhance our understanding of NUP107 dynamics and function?

Advanced imaging techniques are transforming our ability to study NUP107 dynamics and function with unprecedented spatial and temporal resolution:

• Super-Resolution Microscopy Approaches:

  • Structured Illumination Microscopy (SIM) can achieve ~100 nm resolution, allowing visualization of NUP107 arrangement within the nuclear pore complex

  • Stochastic Optical Reconstruction Microscopy (STORM) and Photoactivated Localization Microscopy (PALM) enable single-molecule localization at ~20 nm resolution

  • Stimulated Emission Depletion (STED) microscopy offers live-cell super-resolution imaging of NUP107 dynamics

  • These techniques have revealed previously undetectable details about NPC architecture and nucleoporin distribution

• Live Cell Imaging and Dynamics:

  • Fluorescence Recovery After Photobleaching (FRAP) has already revealed that GFP-tagged NUP107 is tightly attached to NPCs during interphase and exchanged only once per cell cycle

  • Single-particle tracking with photoactivatable fluorescent proteins can trace individual NUP107 molecules

  • Lattice light-sheet microscopy enables long-term 3D imaging with minimal phototoxicity for tracking NUP107 throughout the cell cycle

  • These approaches provide critical insights into the kinetics and regulation of NUP107 incorporation into complexes

• Correlative Light and Electron Microscopy (CLEM):

  • Combining fluorescence imaging of tagged NUP107 with electron microscopy for ultrastructural context

  • Cryo-electron tomography of labeled NPCs can bridge molecular and structural understanding

  • Focused ion beam scanning electron microscopy (FIB-SEM) for 3D ultrastructural analysis of NUP107 distribution

• Functional Imaging Approaches:

  • FRET-based biosensors to detect conformational changes or protein interactions in living cells

  • Optogenetic tools for acute manipulation of NUP107 function or localization

  • Fluorescence Correlation Spectroscopy (FCS) and Number and Brightness (N&B) analysis to quantify NUP107 complex stoichiometry

• Multi-modal Imaging Integration:

  • Combining genomic visualization techniques (like FISH) with NUP107 imaging to correlate with chromatin interactions

  • Multiplexed imaging of NUP107 with interaction partners during key cellular processes

  • Computational image analysis and machine learning for quantitative characterization of complex patterns

These cutting-edge approaches are enabling researchers to move beyond static snapshots to understand the dynamic behavior of NUP107 across spatial scales ranging from single molecules to whole cells, and temporal scales from milliseconds to the entire cell cycle.

How should researchers interpret contradictory results regarding NUP107 function in different experimental systems?

When faced with contradictory results regarding NUP107 function across different experimental systems, researchers should consider several factors that might explain these discrepancies:

• Cell Type-Specific Effects:

  • NUP107 function may vary between cell types due to differential expression of interaction partners

  • Primary cells versus immortalized cell lines may show different dependencies on NUP107

  • Tissue-specific contexts may influence the relative importance of different NUP107 functions

  • For example, while NUP107 depletion shows limited effect on HeLa cell growth , effects may differ in specialized cell types like podocytes where NUP107 has been implicated in disease

• Methodological Considerations:

  • Different depletion methods (siRNA, CRISPR, etc.) may achieve varying levels of protein reduction

  • Acute versus chronic depletion may allow for different compensatory mechanisms

  • The timing of analysis after depletion is critical - early effects may differ from long-term adaptations

  • For instance, RNAi experiments with NUP107 achieved 70-90% transfection efficiency, with the remaining cells potentially influencing population-level analyses

• Functional Redundancy and Compensation:

  • Despite significant NPC structural changes after NUP107 depletion, only partial inhibition of mRNA export was observed, suggesting functional redundancy

  • Compensatory upregulation of other nucleoporins or transport factors may occur in some systems but not others

  • The robustness of these compensatory mechanisms may vary across cell types or experimental conditions

• Isoform-Specific Functions:

  • Multiple isoforms of NUP107 exist , which may have distinct functions

  • Different experimental approaches may preferentially affect specific isoforms

  • The relative expression of these isoforms may vary across experimental systems

• Systematic Approach to Resolving Contradictions:

  • Direct side-by-side comparison using identical methodology across different systems

  • Rescue experiments to confirm specificity of observed phenotypes

  • Comprehensive characterization of depletion efficiency at both RNA and protein levels

  • Detailed analysis of potential compensatory mechanisms through transcriptomics and proteomics

  • Consideration of temporal dynamics in the development of phenotypes

When publishing findings, researchers should clearly describe the experimental system, depletion methodology, timing of analysis, and quantification approaches to facilitate comparison across studies and help resolve apparent contradictions in the literature.

What controls are essential when studying NUP107 localization and expression patterns?

Rigorous controls are essential for accurate interpretation of NUP107 localization and expression studies:

• Antibody Validation Controls:

  • Specificity controls using siRNA or CRISPR-mediated depletion of NUP107 to demonstrate signal reduction

  • Competing peptide controls with the immunizing peptide to verify epitope specificity

  • Multiple antibodies targeting different epitopes to confirm consistent localization patterns

  • Pre-immune serum controls to assess non-specific binding

  • Cross-reactivity testing in systems lacking the target (e.g., knockout cells)

• Localization Controls:

  • Co-staining with established nuclear envelope/NPC markers to confirm proper localization

  • Cell cycle synchronization controls, as NUP107 localization changes during mitosis

  • Counterstaining with DAPI or other nuclear markers to provide context for localization

  • Subcellular fractionation to biochemically validate microscopy-based localization

  • Z-stack imaging to distinguish peripheral from internal nuclear signals

• Expression Analysis Controls:

  • Reference genes/proteins with stable expression for normalization in qPCR or Western blot

  • Loading controls appropriate for the subcellular fraction being analyzed

  • Standard curves with recombinant protein for absolute quantification

  • Positive controls using samples known to express NUP107 (e.g., A549 cells)

  • Negative controls using samples with verified absence of NUP107

• Methodological Controls:

  • For immunofluorescence: Secondary antibody-only controls to assess background

  • For Western blot: Molecular weight markers to confirm expected size (~107 kDa)

  • For tagged proteins: Tag-only expression controls to assess potential tag artifacts

  • For live imaging: Photobleaching controls to account for signal loss

  • Non-specific IgG controls for immunoprecipitation experiments

• Context-Specific Controls:

  • When studying disease-associated changes, matched normal-disease samples processed identically

  • When examining developmental changes, appropriate stage-matched controls

  • For drug treatment studies, vehicle controls and dose-response analyses

  • Time-course controls when studying dynamic processes

Proper implementation and reporting of these controls will strengthen the reliability and reproducibility of findings related to NUP107 localization and expression patterns.

How should researchers approach quantitative analysis of NUP107 in microscopy and biochemical assays?

Robust quantitative analysis of NUP107 requires careful consideration of methodology, controls, and statistical approaches:

• Quantitative Immunofluorescence Microscopy:

  • Signal Intensity Measurement:

    • Define consistent regions of interest (ROIs) for nuclear rim measurements

    • Subtract local background from each measurement

    • Normalize to reference markers when comparing across samples

    • Use digital image processing tools that avoid saturation during acquisition

  • Distribution Analysis:

    • Line scan analysis across the nuclear envelope to quantify rim-to-nucleoplasm signal ratio

    • Colocalization coefficients (Pearson's, Mander's) for co-distribution with other NPC components

    • Spatial statistics for cluster analysis of NUP107 distribution patterns

  • Controls and Standardization:

    • Include fluorescent calibration beads or standards in experiments

    • Apply consistent imaging parameters across all samples

    • Process all comparative samples in parallel to minimize batch effects

• Quantitative Biochemical Assays:

  • Western Blot Quantification:

    • Establish linear detection range using dilution series

    • Include recombinant protein standards for absolute quantification

    • Use fluorescence-based detection for wider linear range compared to chemiluminescence

    • Always normalize to appropriate loading controls

  • Mass Spectrometry Approaches:

    • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) for targeted quantification

    • Stable isotope labeling by amino acids in cell culture (SILAC) for relative quantification

    • Include isoform-specific peptides in analysis when possible

    • Normalize to invariant reference proteins or spike-in standards

• Statistical Analysis Considerations:

  • Determine appropriate sample sizes through power analysis

  • Test data for normality before selecting parametric or non-parametric tests

  • Use appropriate multiple comparison corrections for large-scale analyses

  • Report effect sizes alongside p-values for better interpretation of biological significance

  • Consider hierarchical or mixed models when analyzing multiple cells from the same sample

• Specialized Quantitative Approaches:

  • Fluorescence correlation spectroscopy (FCS) for measuring diffusion and concentration

  • Number and brightness (N&B) analysis for quantifying molecular aggregation states

  • Ratiometric FRET measurements for quantifying protein interactions

  • Automated high-content imaging for large-scale quantitative phenotypic analysis

• Data Presentation Guidelines:

  • Include representative images alongside quantitative plots

  • Clearly indicate number of biological and technical replicates

  • Present full data distributions (e.g., box plots, violin plots) rather than just means

  • Use consistent scales when comparing across conditions

  • Clearly state image processing steps performed before quantification

By implementing these quantitative approaches systematically, researchers can generate more reliable, reproducible, and meaningful quantitative data about NUP107 expression, localization, and function.

What are the most significant unanswered questions in NUP107 research?

Despite significant advances in understanding NUP107 biology, several important questions remain unanswered:

• Structural and Functional Specificity:

  • What specific structural features make NUP107 a "keystone nucleoporin" essential for proper NPC assembly?

  • How does NUP107 mechanistically coordinate the assembly of other nucleoporins into the NPC?

  • What are the specific contributions of NUP107 to nuclear transport that cannot be compensated by other nucleoporins?

• Regulatory Mechanisms:

  • How is NUP107 expression and incorporation into NPCs regulated during development and differentiation?

  • What post-translational modifications control NUP107 function, and how are these regulated?

  • What determines the once-per-cell-cycle exchange rate of NUP107 at NPCs?

• Disease Associations:

  • What is the molecular mechanism by which NUP107 dysfunction contributes to nephrotic syndrome?

  • How does NUP107 function as an HIV dependency factor, and can this be therapeutically targeted?

  • Are there additional disease associations yet to be discovered?

• Evolutionary Perspectives:

  • How has NUP107 function evolved across species, and what does this reveal about essential versus specialized functions?

  • What selective pressures have shaped the evolution of the NUP107 complex?

  • Are there species-specific adaptations in NUP107 structure or function?

• Non-NPC Functions:

  • What is the complete inventory of NUP107's roles beyond its structural function in the NPC?

  • How does NUP107 mechanistically contribute to spindle assembly during mitosis?

  • Are there undiscovered functions in transcriptional regulation or chromatin organization?

Addressing these questions will require integration of structural biology, systems-level approaches, and in vivo models to fully elucidate NUP107's multifaceted roles in cellular function and disease.

How might research on NUP107 evolve in the next five years?

Research on NUP107 is poised for significant evolution over the next five years, driven by technological advances and emerging biological questions:

• Technological Advances:

  • Cryo-electron microscopy will likely provide higher-resolution structures of the NUP107-160 complex within the native NPC context

  • Genome-wide CRISPR screens will uncover synthetic lethal interactions and functional relationships

  • Spatial transcriptomics and proteomics will map local effects of NUP107 on gene expression and protein distribution

  • Advanced light microscopy techniques will enable real-time visualization of NUP107 dynamics during cellular processes

  • AI-driven protein structure prediction and molecular dynamics simulations will generate new hypotheses about NUP107 function

• Translational Research Directions:

  • Development of potential therapeutic approaches targeting NUP107's role as an HIV dependency factor

  • Deeper investigation of NUP107 mutations in nephrotic syndrome and potential treatment strategies

  • Exploration of NUP107's contribution to other diseases through analysis of human genetic data

  • Precision medicine approaches based on patient-specific NUP107 variants

• Fundamental Biology Insights:

  • Comprehensive mapping of the NUP107 interactome across different cellular states

  • Detailed understanding of how NUP107 contributes to nuclear transport selectivity

  • Elucidation of the mechanisms coordinating NUP107's dual functions at NPCs and mitotic structures

  • Discovery of potential roles in cellular stress responses and aging

• Methodological Developments:

  • Development of isoform-specific tools to distinguish functions of different NUP107 variants

  • Optogenetic approaches for acute, spatially-controlled disruption of NUP107 function

  • Novel proximity labeling techniques to capture transient NUP107 interactions

  • Single-cell multi-omics to understand cell-to-cell variability in NUP107 function

• Interdisciplinary Integration:

  • Computational modeling of NPC assembly with NUP107 as a key component

  • Systems biology approaches integrating multiple data types to understand NUP107 in cellular networks

  • Evolutionary analyses to understand selection pressures on NUP107 structure and function

  • Synthetic biology efforts to engineer NPCs with modified NUP107 for novel functions